Ontology highlight
ABSTRACT: Background
Guideline-directed treatment is often withheld in frail patients with heart failure (HF) due to concerns about intolerability, yet they may benefit given the higher risk of HF complications. This systematic review evaluates the efficacy and safety of HF therapy according to frailty levels.Methods
We searched Medline, Embase, and Web of Science for randomized clinical trials on HF therapies reporting outcomes by frailty status (as defined by the study). Data were summarized in a harvest plot, and a meta-analysis was conducted where possible.Results
We identified 12 studies: 6 on medication; 3 on exercise/rehabilitation; and 1 each on disease management programs, telemonitoring, and implantable cardioverter-defibrillators. Most studies found no significant
SUBMITTER: Nijskens CM
PROVIDER: S-EPMC12553454 | biostudies-literature | 2025 Sep
REPOSITORIES: biostudies-literature